Abstract

Peanut allergy is one of the serious health concern and affects more than 1% of the world’s population mainly in Americas, Australia, and Europe. Peanut allergy is sometimes life-threatening and adversely affect the life quality of allergic individuals and their families. Consumption of hypoallergen peanuts is the best solution, however, not much effort has been made in this direction for identifying or developing hypoallergen peanut varieties. A highly diverse peanut germplasm panel was phenotyped using a recently developed monoclonal antibody-based ELISA protocol to quantify five major allergens. Results revealed a wide phenotypic variation for all the five allergens studied i.e., Ara h 1 (4–36,833 µg/g), Ara h 2 (41–77,041 µg/g), Ara h 3 (22–106,765 µg/g), Ara h 6 (829–103,892 µg/g), and Ara h 8 (0.01–70.12 µg/g). The hypoallergen peanut genotypes with low levels of allergen proteins for Ara h 1 (4 µg/g), Ara h 2 (41 µg/g), Ara h 3 (22 µg/g), Ara h 6 (829 µg/g), and Ara h 8 (0.01 µg/g) have paved the way for their use in breeding and genomics studies. In addition, these hypoallergen peanut genotypes are available for use in cultivation and industry, thus opened up new vistas for fighting against peanut allergy problem across the world.

Highlights

  • Food allergy causes severe health issues throughout the globe and the incidences are increasingly recorded across the globe

  • The results have shown great hope toward fighting peanut allergy and

Read more

Summary

Introduction

Food allergy causes severe health issues throughout the globe and the incidences are increasingly recorded across the globe. The 1% population of Canadian children are allergic to peanuts (Ben-Shoshan et al, 2009) while the prevalence of peanut-based allergy in France and Denmark ranged between 0.3-0.75% and 0.2-0.4%, respectively (Morisset et al, 2005; Osterballe et al, 2005). About 3% of Australians are allergic to peanuts and peanut-based products (Sicherer and Sampson, 2007; Sicherer and Sampson, 2014). It is a big problem in the United Kingdom (UK) as well, and the prevalence of sensitization increased from 1.3 to 3.2% in 3 years old kids (Grundy et al, 2002). The countries producing the peanuts and peanut based product with the most safe, nutritious, and healthy features will get a competitive advantage over other producing countries

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call